Bristol AMR

Building on clear areas of success in antimicrobial resistance (AMR) research across faculties, particularly through the UKRI ‘Tackling AMR’ cross-council funding initiative, and via the global challenges research fund, this research strand aims to expand Bristol’s AMR research network, with the objective of developing an interdisciplinary research centre addressing the global challenge of AMR.


Antimicrobials, particularly antibiotics, transformed healthcare in the 20th century and have played a major part in reducing death rates from communicable diseases, particularly paediatric diseases. Unequal access to antimicrobials is a significant reason for inequality in death rates across the globe. The excessive use of antimicrobials, or over-reliance on a few drugs because of unequal access in some parts of the world, has driven selection for AMR to the point where global healthcare systems are being threatened.
The aim of establishing Bristol AMR is to further facilitate the University of Bristol’s diverse AMR research community to come together to compete for future large-scale research funding, cementing our place as the UK centre of excellence for interdisciplinary AMR research and making a real impact on global health.


The Bristol AMR interdisciplinary research community is focusing on three main areas: 
1. Antimicrobial resistance discovery science
  • Antibiotic drug discovery
  • Understanding and blocking resistance
  • Development of novel resistance diagnostics
2. AMR research applications
  • New approaches to infection prevention and treatment
  • Antibiotic usage and behaviour change in clinical practice and livestock production 
  • Controlling antibiotic use through stewardship 
3. AMR in a global context 
  • Understanding the drivers of AMR in human and veterinary healthcare settings 
  • Understanding the drivers of AMR in the community and environment 
  • Understanding regulatory systems relevant to drivers of AMR

Key activities

Our proposed activities are focused on three strategically important areas:
  • Leveraging existing success to promote Bristol AMR and attract potential collaborators, including industrial and low and middle-income countries (LMIC) collaborators, and potential 'exceptional talent' appointments.
  • Building on and expanding the Bristol AMR Interdisciplinary Research Network
  • Deploying funding to develop Global Challenges Research Fund (GCRF)-relevant AMR research, and to translate existing AMR projects.


AMR Research Strand funding call - Spring 2019

Applications were invited for pump-priming projects, translational work and public engagement activities in the area of antimicrobial resistance (AMR) from across the University of Bristol's six faculties.

Find out about the six successful projects to be funded by the recent Bristol AMR EBI Research Strand funding call.


Bristol AMR had its formal launch event during ‘World Antibiotic Awareness Week’ on Wednesday 14 November 2018 at the University of Bristol.  
Read about Bristol AMR Colston Research Society Symposium and Public Lecture on 13 and 14 November 2019: ‘The Age of Antibiotics: The End or a New Beginning?’.


Bristol AMR is a cross-faculty initiative led by:
Professor Matthew Avison
Research Strand Co-Lead, Bristol AMR cross-faculty committee Chair
School of Cellular and Molecular Medicine
Professor Adrian Mulholland
Research Strand Co-Lead
School of Chemistry
Dr Claire Spreadbury 
Bristol AMR Manager
Senior Research Administrator: Pei Hayes 
If you have any enquiries about Bristol AMR please
Edit this page